Back to search

Article

Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI- Driven Biomarkers

2025-11-05

Abstract excerpt

<h4>Background: </h4> /Objectives: Prostate cancer is the most prevalent malignancy in men and remains a leading cause of cancer-related mortality worldwide. Conventional imaging modalities exhibit limited sensitivity, particularly in the context of disease recurrence and advanced disease. <h4>Methods:</h4> A narrative review was conducted of studies published between 2015 and 2025, identified through PubMed, Emba...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b7559d8d-b919-5b1d-a1b4-665c317ae422
DOI
10.20944/preprints202511.0248.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI- Driven BiomarkersDOI 10.20944/preprints202511.0248.v1
Select a neighboring publication to make it the new centre.